Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Buy
2,672
+216
+9% +$28.9K 0.07% 98
2026
Q1
$297K Sell
2,456
-375
-13% -$46.7K 0.06% 93
2025
Q4
$324K Buy
+2,831
New +$303K 0.06% 98
2019
Q1
Sell
-3,191
Closed -$463K 237
2018
Q4
$463K Sell
3,191
-1,830
-36% -$245K 0.12% 131
2018
Q3
$933K Sell
5,021
-1,018
-17% -$174K 0.24% 69
2018
Q2
$1.12M Sell
6,039
-15
-0.2% -$2.94K 0.27% 81
2018
Q1
$1.13M Buy
6,054
+899
+17% +$169K 0.27% 81
2017
Q4
$911K Buy
5,155
+2,068
+67% +$363K 0.22% 90
2017
Q3
$534K Sell
3,087
-2,069
-40% -$313K 0.13% 159
2017
Q2
$733K Buy
+5,156
New +$730K 0.18% 116

Other funds holding LEA

USA Financial Formulas's LEA Position: Q2 2026 in Review

USA Financial Formulas increased its Lear (LEA) stake by 8.8% in Q2 2026, buying an estimated $28.9K and bringing the position to 2,672 shares worth $358K. The position accounts for 0.07% of the portfolio, ranked #98.

USA Financial Formulas first reported a position in LEA in Q2 2017 and has held it in 10 quarters since. The position peaked at $1.13M in Q1 2018. 520 funds tracked by Wall St. Rank hold LEA as of Q2 2026.

  • USA Financial Formulas held 2,672 shares of Lear worth $358K as of Q2 2026.
  • USA Financial Formulas bought 216 Lear shares in Q2 2026, an estimated $28.9K.
  • Lear made up 0.07% of USA Financial Formulas's portfolio in Q2 2026, its #98 holding.
  • USA Financial Formulas first reported a position in Lear in Q2 2017 and has held it in 10 quarters since.
  • USA Financial Formulas's Lear position peaked at $1.13M in Q1 2018.
  • 520 funds tracked by Wall St. Rank held Lear as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.